Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Non-cash Items (2018 - 2021)

Cogent Biosciences has reported Non-cash Items over the past 4 years, most recently at $42.6 million for Q3 2021.

  • Quarterly results put Non-cash Items at $42.6 million for Q3 2021, changed N/A from a year ago — trailing twelve months through Sep 2021 was $42.6 million (changed N/A YoY), and the annual figure for FY2020 was $19.6 million, up 6005.92%.
  • Non-cash Items for Q3 2021 was $42.6 million at Cogent Biosciences, down from $43.7 million in the prior quarter.
  • Over the last five years, Non-cash Items for COGT hit a ceiling of $43.7 million in Q2 2021 and a floor of $321000.0 in Q4 2019.
  • Median Non-cash Items over the past 4 years was $22.0 million (2020), compared with a mean of $22.6 million.
  • Biggest five-year swings in Non-cash Items: crashed 93.6% in 2019 and later skyrocketed 6005.92% in 2020.
  • Cogent Biosciences' Non-cash Items stood at $5.0 million in 2018, then crashed by 93.6% to $321000.0 in 2019, then skyrocketed by 6005.92% to $19.6 million in 2020, then skyrocketed by 117.35% to $42.6 million in 2021.
  • The last three reported values for Non-cash Items were $42.6 million (Q3 2021), $43.7 million (Q2 2021), and $24.5 million (Q1 2021) per Business Quant data.